Contract research organisations β also called clinical research organisations CROs β are essential to the pharma, biotech, and medtech industries, supporting their efforts to test, refine and market their latest drugs and devices.
Whilst throughout the height of Covid years we saw record numbers of hires across the industry, it has become apparent that the pandemic-driven unprecedented acceleration has slowed down. The year of was peppered by consolidation, reorganisations and cautious hiring. Whilst in we find ourselves neither at the height of volume-based hiring, or in the depths of layoffs, we are still navigating challenging times. With expansions, partnerships, and innovations continuing throughout the CRO industry, is set to be another interesting year.
The top ten CROs to watch in are listed below, this list is based on our knowledge of the industry and is in no particular order but includes both industry leaders by market share and revenue, and up-and-comers who are steadily increasing their presence through strategic collaboration and innovative service offerings.
Founded over 40 years ago and providing the full range of Phase I to IV clinical development services to help speed up and ensure the drug approval process runs smoothly, Parexel remains one of the biggest CROs in the world. With a team of more than 21, professionals worldwide, the company has a wide range of service offerings, covering nearly every type of clinical trial service to assist sponsors in running successful clinical studies.
:max_bytes(150000):strip_icc()/Fisher-effect-final-dfeba6063c124342a17bdb80b7417b48.png "Teen girls in Fishers")
Together, Parexel and Goldman Sachs remain committed to delivering on the patient-first trajectory and driving advancements in drug development. In , Parexel announced a innovative collaboration with AI company Partex. The partnership combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their innovation medical advancements.
